Other studies evaluated the plasma levels of IGF-1 as a potential biomarker in BD patients (Palomino et al., 2013; Kim et al., 2013; Liu et al., 2014; da Silva et al., 2017; Tuncel et al., 2020). The gene discussed is IGF1; the disease is Behcet disease.